Log in to search using one of your social media accounts:

Should You Have a Scan for Skin Cancer?
Some doctors say individuals at high risk for skin cancer should have one head-to-toe exam a year . (Source: WSJ.com: Health)
Source: WSJ.com: Health - April 4, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Mylan Hit With Lawsuit Alleging It Overcharged EpiPen Patients
Mylan NV was hit Monday with a lawsuit alleging the drug company overcharged EpiPen patients. (Source: WSJ.com: Health)
Source: WSJ.com: Health - April 3, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Pence Breaks Tie on Bill Targeting Planned Parenthood Funding
Vice President Mike Pence cast the tiebreaking votes in the Senate on a measure that would enable states to strip some federal funds from Planned Parenthood and other health-care providers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 30, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Kansas Governor Vetoes Medicaid Expansion
Kansas ’ Republican governor vetoed a bill to expand Medicaid, two days after the state’s GOP-led legislature approved extending eligibility for the program under the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 30, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Ryan Signals Support for Insurance Payments Under ACA
House Speaker Paul Ryan said the Trump administration should continue making payments to insurers under the Affordable Care Act to avoid destabilizing the market. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 30, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

CtW Investment Calls for Governance Changes at Universal Health Services
An adviser to pension funds invested in hospital company Universal Health Services said it will oppose reelection of a UHS director unless the company promises to overhaul its governance. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA Approves Drug for Primary Progressive Multiple Sclerosis
The FDA approved a Genentech multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of MS. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA Approves Regeneron and Sanofi's Dupixent for Eczema
Regeneron Pharmaceuticals and Sanofi said they will charge $37,000 annually in the U.S. for their newly approved eczema drug, a price the companies said they reached after months of negotiations with pharmacy benefit managers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

More States Weigh Expanding Medicaid After GOP Health Bill's Demise
A growing number of states are considering expanding their Medicaid programs under the Affordable Care Act, after last week ’s abrupt collapse of the GOP health bill and a development that could make it harder for Republicans to undo the law in the future. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Kansas GOP-Led Legislature Approves Medicaid Expansion
Lawmakers voted to extend Medicaid to cover more than 150,000 additional nondisabled adults under the Affordable Care Act, just days after Republicans in Washington pulled their bill to repeal and replace the law known as Obamacare. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Vertex Seeks Approval for Experimental Cystic-Fibrosis Drug
Vertex Pharmaceuticals said it would seek regulatory approval for one of its experimental cystic-fibrosis drugs after the treatment helped improve patients ’ lung function in late-stage studies. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 28, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Starboard Wins More Board Seats, Replaces CEO at Depomed
Specialty pharmaceuticals maker Depomed has replaced its chief executive and named two new directors to its board after nearly a year of activist pressure from Starboard Value LP. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 28, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Elon Musk's Latest Startup: Brains Linked to Computers
Billionaire entrepreneur Elon Musk wants to merge computers with human brains to help people keep up with machines. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 28, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Can Tech Speed Up Emergency Room Care?
A New York hospital system tests a new way to use telemedicine, where E.R. doctors examine patients without being in the same room. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

After GOP Bill's Failure, Health-Law Lawsuit Takes Center Stage
President Donald Trump and GOP lawmakers, seeking to regroup following the collapse of the effort to repeal the Affordable Care Act, have an option for gutting the health law relatively quickly: They could halt billions in payments insurers get under the law. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Valeant Former CEO Sues Company Over Unmade Payments
Michael Pearson, ex-CEO of Valeant Pharmaceuticals, is suing the embattled drugmaker for refusing to pay him more than 3 million company shares that he said he is owed. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Ryan Confident About Health Plan's Passage
Paul Ryan  expressed confidence that the Republican health-care plan will pass the House later this week, saying his party’s lawmakers are working to make changes to the bill to address remaining concerns, including providing more assistance to older Americans. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 20, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

A Prescription Blood Thinner Beat Aspirin at Preventing Recurrence of Blood Clots, Study Finds
A Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson& Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Young People to Pay Less Under GOP Health Plan, CBO Says
A federal analysis of a Republican health plan that shows it would leave millions more uninsured has a silver lining for GOP leaders: In general, premiums under their proposal would eventually come down for younger people. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Senators Say House Health Bill Won't Pass Without Changes
Republican senators, alarmed by a nonpartisan report showing millions would lose insurance under the GOP health-care plan, warned Tuesday that the bill wouldn ’t become law without fundamental changes. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks
The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

After CBO Report, Democrats See Opening on Health Care
Democrats, after playing defense on health care for nearly a decade, are trying to turn the issue to their advantage in next year ’s midterm elections, targeting in particular lawmakers who have already voted for the GOP health bill. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Generic Drugmakers Can Live With a Speedier FDA
FDA chief nominee Scott Gottlieb ’s changes may pressure generic drug prices, but there are other positives for the sector. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

AstraZeneca Gives Rejected Drugs a Second Life
AstraZeneca is working with outside researchers to look for untapped potential in drugs that the company has shelved, part of a broader move to improve its research-and-development output. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Pershing Square Sold Stake in Valeant
William Ackman ’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

CBO Sees 24 Million More Uninsured, $337 Billion Deficit Cut With GOP Plan
The number of Americans without health insurance would grow by 24 million under a House Republican proposal to topple most of the Affordable Care Act, according to a nonpartisan report that is likely to complicate GOP lawmakers ’ efforts to unite around the plan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

After Record Year for Fatal Overdoses, New York City Targets Opioids
New York City will spend $38 million annually to combat an opioid epidemic that killed more than 1,000 New Yorkers last year, city officials said  Monday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Seema Verma Confirmed as Head of Centers for Medicare and Medicaid Services
Seema Verma, President Donald Trump ’s pick to oversee the Medicare and Medicaid programs, won Senate confirmation in a largely party-line vote Monday, placing an advocate of overhauling Medicaid at the program’s helm. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Health Plan Would Hit Rural Areas Hard
The House Republican effort to overhaul the Affordable Care Act could hit many rural areas particularly hard, sharply increasing the cost for some residents buying their own insurance. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Health Plan Advances After Clearing Two Panels
Republicans in Congress scored a victory in their efforts to replace parts of the Affordable Care Act, pushing measures through two House committees. But opposition to the health overhaul remains strong. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Soda Loses Its U.S. Crown: Americans Now Drink More Bottled Water
Americans now officially drink more bottled water than soda. It ’s a shift that decades ago might have seemed unthinkable—that consumers would buy a packaged version of something that was free from a tap. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Alliance of Companies Unveil First Steps to Cutting Health-Care Costs
A U.S. alliance formed last year by more than three dozen companies, including American Express Co., Johnson& Johnson and Macy ’s Inc., is announcing its first plans aimed at lowering the companies’ health-care spending. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

GOP's Health Plan Draws Skepticism on Capitol Hill
President Donald Trump on Tuesday backed House Republicans ’ proposal to repeal and replace the Affordable Care Act, but emerging conservative opposition threatened to derail the contentious plan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Health-Care Companies See Big Risks in Plan to Replace Obamacare
Though they are applauding the elimination of some taxes, insurers foresee problems from the cancellation of penalties for going without health coverage. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 8, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Lawmaker Tries to Steer Through Tricky Terrain on ACA
As Republicans dive into their politically risky push to undo the Affordable Care Act, Rep. Greg Walden is emerging as a key figure in the party ’s attempt to rally around a new health-insurance system. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 7, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

House Republicans Release Plan to Replace Obamacare
House Republicans released a detailed proposal that marks their first attempt in the new Congress to unite GOP members behind a plan to replace the Affordable Care Act and deliver on a central campaign promise. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 7, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Bird Flu Found at Farm Affiliated With Tyson
The first case of highly pathogenic avian influenza to strike a commercial poultry flock in more than a year has been found on a Tennessee chicken farm affiliated with Tyson Foods. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Race Tightens for Next Wave of Cancer Drugs
Incyte, which operates out of an old department store in Delaware, is one of the closest to market with a new class of immunotherapies. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Marathon Faces Scrutiny for Price of Muscular Dystrophy Drug
A group of U.S. senators is examining Marathon Pharmaceuticals LLC ’s decision to charge $89,000 in the U.S. for an old steroidal drug that costs a fraction of that overseas, the latest sign of growing scrutiny of the company. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

New Jersey Complex Finds New Life as a Home for Several Firms
A 110-acre research complex in Bridgewater, N.J., seemed poised a few years ago to join the growing ranks of suburban office campuses left for dead, but a joint venture of investors is breathing life into the property. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 6, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Actelion's Founding Couple Starts New Biotech, With J & J's Backing
The founders of Swiss biotech company Actelion, which has been sold to J&J, are starting over again —creating a new biotech player with nearly $1 billion in capital, a deep-pocketed partner in J&J and soon, a stock listing in Zurich. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 3, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Roche Shares Boosted by Cancer Drug Trial Success
Roche shares rose sharply after the company reported a clinical trial success that could help cushion it against looming competition for Herceptin and boost sales for its newer Perjeta drug. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 2, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Drug Companies Block Shareholders' Voting on Price Transparency
Several major U.S. drug companies, including Pfizer and Merck, have squelched an investor campaign aimed at forcing companies to disclose more information about when and why they raise prices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 2, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Valeant's Revenue Falls 13%
Valeant Pharmaceuticals said its revenue fell 13% in the fourth quarter, hurt by the performance of the stomach-drug business it tried to sell late last year as well as lower drug prices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 1, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Johnson & Johnson Prescription Unit List Prices Rose 8.5% Last Year
Johnson& Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year —and 3.5% after discounts—in the health-products company’s first effort to address criticism about the high cost of medicines by opening up about its drug-pricing practices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

How to Get Patients to Take More Control of Their Medical Decisions
For years, people have been urged be more active in their own care. Now providers are giving them better tools to make that happen. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

GOP Leaders Dare Fellow Republicans to Block Obamacare Repeal
Republican leaders are betting that the only way for Congress to repeal the Affordable Care Act is to set a bill in motion and gamble that fellow GOP lawmakers won ’t dare to block it. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

GOP Governors at Health-Law Impasse
Governors meeting Saturday to discuss health-care policy said they hadn ’t reached a consensus on the future of the Medicaid program, an issue hamstringing Republicans’ bid to alter the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Facing Criticism, Drug Makers Keep Lid On Price Increases
Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President Trump. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

Trump Administration Seeks Delay in Lawsuit Over Health-Law Subsidies
The Trump administration and House Republicans on Tuesday asked a court for a further delay in a lawsuit over certain Affordable Care Act subsidies, a move that may help assuage insurers debating whether to participate in the health law ’s 2018 exchanges. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news